Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that ...

Akagera Medicines has reported positive data from the single-ascending dose (SAD) segment of its first-in-human Phase I trial ...

African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal tuberculosis (TB). The scientists' system can breach the heart's protective ...

SAN DIEGO (FOX 5/KUSI) — Anyone who attended St. Michael’s Catholic Church in the Paradise Hills area of San Diego from Sept. 22 to Dec. 1, 2024, is being warned they could have potentially been ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...

The Experimental Tuberculosis Unit (UTE) at the Germans Trias i Pujol Research Institute (IGTP) has published in Nature ...

Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people each year and caused and estimated 1.25 million deaths in 2023. 1,2 While ...

The World Health Organization ( WHO ) has labelled tuberculosis as the world's leading infectious disease killer. With more than 10 million cases of active tub ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Tuberculosis (TB), one of the leading infectious disease killers ...

A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...